Significance of matrix metalloproteinase-2, -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium

Anticancer Research

Volumn 27, Issue 1 A, 2007, Pages 95-106

  Obokata, Akane ^a   Watanabe, Jun ^b   Nishimura, Yukari ^a   Arai, Tsutomu ^a,b   Kawaguchi, Miwa ^a,b   Kuramoto, Hiroyuki ^a,b  

^a KITASATO UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endometrial menstrual cycle; Endometrial neoplasia; MMP 11; MMP 7; TIMP 1

Indexed keywords

ESTROGEN RECEPTOR; GELATINASE A; INTERSTITIAL COLLAGENASE; MATRILYSIN; STROMELYSIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; CANCER INVASION; CARCINOGENESIS; CORRELATION ANALYSIS; DISEASE COURSE; ENDOMETRIOID CARCINOMA; ENDOMETRIUM; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM TUMOR; ENZYME ANALYSIS; ENZYME DEGRADATION; ENZYME LOCALIZATION; ENZYME REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL ANALYSIS;

ADENOCARCINOMA; CYTOPLASM; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 11; MATRIX METALLOPROTEINASE 7; NEOPLASM STAGING; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 33847672320     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Bauer EA, Stricklin GP, Jeffrey JJ and Eisen AZ: Collagenase production by human skin fibroblasts. Biochem Biophys Res Commun 64: 232-240, 1975.
2. Woolley DE, Roberts DR and Evanson JM: Inhibition of human collagenase activity by small molecular weight serum protein. Biochem Biophys Res Commun 66: 747-754, 1975.
3. Docherty AJP, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJ, Murphy G and Reynolds JJ: Sequence of human tissue inhibitor of metalloproteinase and its identity to erythroid-potentiating activity. Nature 318: 66-69, 1985.
4. Hampton AL and Salamonen LA: Expression of messenger ribonucleic acid encoding matrix metalloproteinases and their tissue inhibitors is related to menstruation. J Endocrinol 141: R1-R3, 1994.
5. Rodgers WH, Matrisian LM, Giudice LC, Dsupin B, Cann P, Svitek C, Gorstein F and Osteen KG: Pattern of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest 94: 946-953, 1994.
6. Singer CF, Marbaix E, Kokorine I, Lemoine P, Donnez J, Eeckhout Y and Courtoy PJ: Paracrine stimulation of interstitial collagenase (MMP-1) in the human endometrium by interleukin la and its dual block by ovarian steroids. Proc Natl Acad Sci USA 94: 10341-10345, 1997.
7. Goffin F, Munaut C, Frankenne F, Hauterive SP, Beliard A, Fridman V, Nervo P, Colige A and Foidart JM: Expression pattern of metalloproteinase and tissue inhibitors of matrix-metalloproteinase in cycling human endometrium. Biol Reprod 69: 976-984, 2003.
8. Mizumoto H, Saito T, Ashihara K, Nishimura M, Takehara M, Tanaka R, Ito E and Kudo R: Expression of matrix metalloproteinases in ovarian endometriomas: immnuhistochemical study and immunoassay. Life Sci 71: 259-273, 2002.
9. Nayak NR, Critchley HOD, Slayden OVD, Menrad A, Chwalisz K, Baird DT and Brenner RM: Progesterone withdrawal upregulates vascular endometrial growth factor receptor type 2 in the superficial zone stroma of the human and macaque endometrium: potential relevance to menstruation. J Clin Endocrinol Metab 85: 3442-3452, 2000.
10. Irwin JC, Klrk D, Gwatkin RBL, Narve M, Cannon P and Gludice LC: Human endometrial matrix metalloproteinase-2, a putative menstrual proteinase. Hormone regulation in cultured stromal cells and messenger RNA expression during the menstrual cycle. J Clin Invest 97: 438-447, 1996.
11. Freitas S, Meduri G, Nestour EL, Bausero P and Perrot-Applanat M: Expression of metalloproteinases and their inhibitors in blood vessels in human endometrium. Biol Reprod 61: 1070-1082, 1999.
12. Cork BA, Turckerman EM, Li TC and Laird SM: Expression of interleukin (IL)-11 receptor by the human endometrium in vitro and effects of IL-1, IL-6 and LIF on the production of MMP and cytokines by human endometrial cells in vitro. Mol Hum Reprod 8: 841-848, 2002.
13. Talvensaari-Mattila A, Santala M, Soini Y and Turpeenniemi-Hujanen T: Prognostic value of matrix metalloproteinase-2 (MMP-2) expression in endometrial endometrioid adenocarcinoma. Anticancer Res 25: 4101-4106, 2005.
14. Graesslin O, Cortez A, Fauvet R, Lorenzato M, Birembaut P and Darai E: Metalloproteinase-2, -7 and -9 and tissue inhibitor of metalloproteinase-1 and -2 expression in normal, hyperplastic and neoplastic endometrium: a clinical-pathological correlation study. Ann Oncol 17: 637-645, 2006.
15. Osteen KG, Rodgers WH, Gaire M, Hargrove JT, Gorstein F and Matrisian LM: Stromal-epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium. Proc Natl Acad Sci USA 91: 10129-10133, 1994.
16. Rodgers WH, Osteen KG, Matrisian LM, Navre M, Giudice LC and Gorstein F: Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle. Am J Obstet Gynecol 168: 253-260, 1993.
17. Tunuguntla R, Ripley D, Sang QXA and Chegini N: Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinase TIMP-3 and -4 in benign endometrium and endometrial cancer. Gynecol Oncol 89: 453-459, 2003.
18. Chegini N, Rhoton-Vlasak A and Williams RS: Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding. Fertil & Steril 80: 564-570, 2003.
19. Zhng J and Salamonsen LA: Tissue inhibitor of metalloproteinases (TIMP)-1,-2,-3 in human endometrium during the menstrual cycle. Mol Human Reprod 3: 735-741, 1997.
20. Ueno H, Yamashita K, Azumano I, Inoue M and Okada Y: Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas. Int J Cancer 84: 470-477, 1999.
21. Nezza LAD, Misajon A, Zhang J, Jobing T, Quinn MA, Oster AG, Nie G, Lopata A and Salmonsen LA: Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Cancer 94: 1466-1475, 2002.
22. Isaka K, Nishi H, Nakai H, Nakada T, Li YF, Ebihara Y and Takayama M: Matrix metalloproteinase-26 is expressed in endometrial carcinoma. Cancer 97: 79-89, 2003.
23. Huang HY, Wen Y, Irwin JC, Kruessel JS, Soong YK and Polan ML: Cytokine-mediated regulation of 92-kilodalton type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-3 messenger ribonucleic acid expression in human endometrial stromal cells. J Clin Endocrinol Metab 83: 1721-1729, 1998.
24. Singer CF, Marbaix E, Lemoine P, Courtoy PJ and Eeckhout Yves: Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts. Eur J Biochem 259: 40-45, 1999.
25. Zhang XL, Simmen FA, Michel FJ and Simmen RCM: Increased expression of the Zn-finger transcription factor BTEB1 in human endometrial cells is correlated with distinct cell phenotype, gene expression patterns, and proliferative responsiveness to serum and TGF-β1. Mol Cell Endocrinol 181: 81-96, 2001.
26. Bruner KL, Rodgers WH, Gold LI, Korc M, Hargrove JT, Matrisian LM and Osteen KG: Transforming growth factor-β mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci USA 92: 7362-7366, 1995.
27. Park YH, Ryu HS, Choi DS, Chang KH, Park DW and Min CK: Effects of hepatocyte growth factor on the expression of matrix metalloproteinases and their tissue inhibitors during the endometrial cancer invasion in a three-dimensional co-culture. Int J Gynecol Cancer 13: 53-60, 2003.
28. Machin P, Catasus L, Pons C, Munoz J, Matias-Guiu X and Prat J: CTNNB1 mutations and β-catenin expression in endometrial carcinomas. Human Pathol 33: 206-212, 2002.
29. Ohta S, Imai K, Yamashita K, Matsumoto T, Azumano I and Okada Y: Expression of matrix metalloproteinase 7 (matrilysin) in human osteoarthritic cartilage. Lab Invest 78: 79-87, 1998.
30. Schatz F, Papp C, Toth-PAL E and Lockwood CJ: Ovarian steroid-modulated stromelysin-1 expression in human endometrial stromal and decidual cells. J Clin Endocrinol Metab 78: 1467-1472, 1994.
31. Salamonsen LA, Butt AR, Hammond FR, Garcia S and Zhang J: Production of endometrial matrix metalloproteinases, but not their tissue inhibitors, is modulated by progesterone withdrawal in an in vitro model for menstruation. J Clin Endocrinol Metab 82: 1409-1415, 1997.
32. Curry TE and Osteen KG: The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocrin Reviews 24: 428-465, 2003.
33. Curry TE and Osteen KG: Cyclic change in the matrix metalloproteinase system in the ovary and uterus. Biol Reprod 64: 1285-1296, 2001.
34. Mizumoto H, Saito T, Ashihara K, Mishimura M, Tanaka R and Kudo R: Acceleration of invasive activity via matrix metalloproteinases by transfection of the estrogen receptor-α gene in endometrial carcinoma cells. Int J Cancer 100: 401-406, 2002.
35. Nezza LAD, Jobling T and Salmonsen LA: Progestin suppresses matrix metalloproteinase production in endometrial cancer. Gynecol Oncol 89: 325-333, 2003.
36. FIGO news, Corpus cancer staging. Int J Gynecol Obstet 28: 189-193, 1989.
37. Palmer SS, Haynes-Johnson D, Diehl T and Nowak RA: Increased expression of stromelysin-3 mRNA in leiomyomas (uterine fibroids) compared with myometrium. J Soc Gynecol Invest 5: 203-209, 1998.
38. Hara T, Tanaka S, Sato H, Seiki M, Tojo H and Tachi C: Expression of matrix metalloproteinase-11 (stromelysin-3) and TIMP-1 genes in the placenta and the uterus during estrous cycles and gestation in the mouse. J Reprod Dev 41: 287-292, 1995.
39. Yamamoto H, Iku S, Adachi Y, Imusumran A, Taniguchi H, Nosho K, Min Y, Horiuchi S, Yoshida M, Itoh F and Imai K: Association of trypsin expression with tumor progression and matrilysin expression in human colorectal cancer. J Pathol 199: 176-184, 2003.
40. Miwa S, Miyagawa S, Soeda J and Kawasaki S: Matrix metalloproteinase-7 expression and biologic aggressiveness of cholangiocellular carcinoma. Cancer 94: 428-434, 2002.
41. Nakopoulou L, Panayotopoulou EG, Gainnopoulou I, Alexandrou P, Katsarou S, Athanassiadou P and Keramopoulos A: Stromelysin-3 protein in invasive breast cancer: relation to proliferation, cell survival and patients' outcome. Mod Pathol 15: 1154-1161, 2002.
42. Thewes M, Worret WI, Engst R and Ring J: Stromelysin-3 (ST-3): immunohistochemical characterization of the matrix metalloproteinase (MMP)-11 in benign and malignant skin tumors and other skin disorders. Clin Exp Dermatol 24: 122-126, 1999.
43. Cribier B, Noacco G, Peltre B and Grosshans E: Stromelysin-3 expression: a useful marker for the differential diagnosis dermatofibroma versus dermatofibrosarcoma protuberans. J Am Acad Dermatol 46: 408-413, 2002.
44. Maatta M, Soini Y, Liakka A and Auto-Harmainen H: Localization of MT1-MMP, TIMP-1, TIMP-2, and TIMP-3 messenger RNA in normal, hyperplastic, and neoplastic endometrium. Enhanced expression by endometrial adenocarcinomas is associated with low differentiation. Am J Clin Pathol 114: 402-411, 2000.